Brooks Cash
The University of Texas Health Sciences Center at Houston · University of South Alabama
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brooks Cash as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:43 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03898856 · Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV PatientsThe University of Texas Health Science Center, Houston · completed · Chronic Diarrhea of Unknown Origin · principal investigator
- N/ANCT02754661 · Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.Medtronic - MITG · completed · Colorectal Cancer Screening · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:43 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Gastrointest Endosc · 2018237 citationsRCR 15.1
- Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.Gastroenterology · 2016227 citationsRCR 10.3
- A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.Dig Dis Sci · 2016108 citationsRCR 5.5
- Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses.Gastrointest Endosc · 199982 citationsRCR 3.0
- Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.Am J Gastroenterol · 201770 citationsRCR 3.6
- 58 citationsRCR 3.7
- Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.Am J Gastroenterol · 201743 citationsRCR 2.1
- Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.Dig Dis Sci · 201739 citationsRCR 1.9
- Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study.Am J Gastroenterol · 201938 citationsRCR 2.0
- Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE).Neurogastroenterol Motil · 202331 citationsRCR 4.1